AlessiaPelleri1 Profile Banner
Alessia Pellerino Profile
Alessia Pellerino

@AlessiaPelleri1

Followers
225
Following
399
Statuses
266

Neurologist/NeuroOncologist, @EORTC BTG, @EURACAN Ultrare #braintumor, @EAN Panel of Neuro-oncology

Torino, Piemonte ๐Ÿ‡ฎ๐Ÿ‡น
Joined January 2015
Don't wanna be here? Send us removal request.
@AlessiaPelleri1
Alessia Pellerino
9 days
World Cancer Day...focus on brain metastases ๐Ÿง  @sinneurologia #braintumor
@sinneurologia
SOCIETร€ ITALIANA DI NEUROLOGIA
9 days
๐†๐ˆ๐Ž๐‘๐๐€๐“๐€ ๐Œ๐Ž๐๐ƒ๐ˆ๐€๐‹๐„ ๐‚๐Ž๐๐“๐‘๐Ž ๐ˆ๐‹ ๐‚๐€๐๐‚๐‘๐Ž Dott.ssa ALESSIA PELLERINO, Unitร  di Neuro-Oncologia AOU Cittร  della Salute e della Scienza di Torino. Gruppo di Studio โ€œNEURO-ONCOLOGIAโ€ della Societร  Italiana di Neurologia. #giornatamondialecontroilcancro
0
0
1
@AlessiaPelleri1
Alessia Pellerino
3 months
RT @oncodaily: ๐Ÿ“ขHighlights from SNO 2024 The SNO 2024 conference in Houston highlighted groundbreaking advancements in brain cancer researโ€ฆ
0
13
0
@AlessiaPelleri1
Alessia Pellerino
3 months
Amazing Priya Kumthekar summarizes CSF liquid biopsy for diagnosis and novel CSF delivery tools for treatment of LM @NeuroOnc #SNO2024
Tweet media one
0
2
7
@AlessiaPelleri1
Alessia Pellerino
3 months
RT @MrugalaMaciej: Great initiative of RANO group on systematizing liquid biopsy in Neuro-Oncology presented by Riccardo Soffietti at #SNO2โ€ฆ
0
2
0
@AlessiaPelleri1
Alessia Pellerino
3 months
RT @NeuroOnc: "Never give up, focus, and give 100%. It's not about us. It's about the patients and their loved ones. It's about them." - Miโ€ฆ
0
2
0
@AlessiaPelleri1
Alessia Pellerino
3 months
โ€œMedian OS in the eflornithine + lomustine arm was 34.9 months compared to 23.5 months in the lomustine alone arm with HR = 0.64 (log rank p = 0.016).โ€
0
0
1
@AlessiaPelleri1
Alessia Pellerino
3 months
0
0
0
@AlessiaPelleri1
Alessia Pellerino
4 months
Thanks @GrupoGeino and @EPineda_ONCO for the wonderful opportunity to talk on ONC-201 @chimerix in K27M mutated midline gliomas, looking forward to further collaboration ๐Ÿ‡ช๐Ÿ‡ฆ๐Ÿค๐Ÿ‡ฎ๐Ÿ‡น
Tweet media one
1
4
6
@AlessiaPelleri1
Alessia Pellerino
4 months
a novel special issue on "New Perspectives in the Management of Central Nervous System (CNS) Tumors" for submitting papers, especially for youngster researchers and investigators
0
0
0
@AlessiaPelleri1
Alessia Pellerino
4 months
Dramatic response after BRAF/MEK inhibitors in BRAF mutated craniopharyngioma...many questions still opened, including if cfDNA is feasible to monitor response @EANOassociation #EANO2024
Tweet media one
0
4
8
@AlessiaPelleri1
Alessia Pellerino
4 months
Great overview on correlations of molecular signatures, grading, locations, and outcomes in skull based tumors @EANOassociation #eano2024
Tweet media one
0
1
1
@AlessiaPelleri1
Alessia Pellerino
4 months
Mechanisms of resistance and impact of D-2HG in impairing microglia activation following IDH inhibitors...trials in combination with ICIs are awaited @EANOassociation #eano2024
Tweet media one
Tweet media two
0
1
3
@AlessiaPelleri1
Alessia Pellerino
4 months
A new corridor for lepto metastases, the integrin ฮฑ6 and the GDNF signaling axis to bypass BBB: new therapeutic targets against breast cancer LM?
0
0
0
@AlessiaPelleri1
Alessia Pellerino
4 months
Amazing talk @veronica_rendo
1
0
0
@AlessiaPelleri1
Alessia Pellerino
4 months
Can't wait the #EANO2024 ๐Ÿง , see you in Glasgow โ€ผ๏ธ๐Ÿ”
@EANOassociation
EANO
4 months
๐ŸŽ‰Very proud to present this year's #EANO conference ambassadors โ€“ part 1! Follow them on X for expert insights and join the conversation using the official hashtag #EANO2024 in #Glasgow๐Ÿ‘‰ @max5tall @valientelab @GeurtsMarjolei @AlessiaPelleri1 @platten_michael #btsm
Tweet media one
0
3
12
@AlessiaPelleri1
Alessia Pellerino
4 months
0
0
2
@AlessiaPelleri1
Alessia Pellerino
4 months
A new proposal of targeting the microenvironment of brain mets, what a wonderful paper ๐Ÿง  Check the info of SILMET trial
@valientelab
Manuel Valiente
4 months
1/13 In our new @CD_AACR paper we report an improved strategy to apply immunotherapy to brain metastasis, specially to those that are symptomatic, which has been reported to poorly respond to immune checkpoint blockade antibodies.
0
0
5